Natera Total Long Term Liabilities 2014-2024 | NTRA

Natera total long term liabilities from 2014 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Natera total long term liabilities for the quarter ending September 30, 2024 were $0.411B, a 10.5% increase year-over-year.
  • Natera total long term liabilities for 2023 were $0.369B, a 2.41% decline from 2022.
  • Natera total long term liabilities for 2022 were $0.378B, a 3.84% increase from 2021.
  • Natera total long term liabilities for 2021 were $0.364B, a 47.54% increase from 2020.
Natera Annual Total Long Term Liabilities
(Millions of US $)
2023 $369
2022 $378
2021 $364
2020 $247
2019 $124
2018 $122
2017 $84
2016 $8
2015 $
2014 $24
2013 $22
Natera Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $411
2024-06-30 $366
2024-03-31 $368
2023-12-31 $369
2023-09-30 $372
2023-06-30 $375
2023-03-31 $377
2022-12-31 $378
2022-09-30 $380
2022-06-30 $371
2022-03-31 $371
2021-12-31 $364
2021-09-30 $353
2021-06-30 $353
2021-03-31 $354
2020-12-31 $247
2020-09-30 $245
2020-06-30 $243
2020-03-31 $123
2019-12-31 $124
2019-09-30 $158
2019-06-30 $163
2019-03-31 $144
2018-12-31 $122
2018-09-30 $119
2018-06-30 $118
2018-03-31 $118
2017-12-31 $84
2017-09-30 $82
2017-06-30 $9
2017-03-31 $9
2016-12-31 $8
2016-09-30 $6
2016-06-30 $2
2016-03-31
2015-12-31
2015-09-30 $21
2015-06-30 $25
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31 $22
Sector Industry Market Cap Revenue
Medical Medical Services $21.401B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00